Repair of DNA Covalently Linked to Protein

Molecular Cell

Volumn 13, Issue 3, 2004, Pages 307-316

  Connelly, John C ^a   Leach, David R F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENZYME; DNA BINDING PROTEIN; DNA TOPOISOMERASE; NUCLEIC ACID; PHOSPHODIESTERASE; PROTEIN; PROTEIN SUBUNIT; PROTEIN TDP1; RAD50 PROTEIN; TYROSYL DNA PHOSPHODIESTERASE; TYROSYL-DNA PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL; ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BINDING SITE; CATALYSIS; CONFORMATION; CORRELATION ANALYSIS; COVALENT BOND; DISEASE ASSOCIATION; DNA DAMAGE; DNA MODIFICATION; DNA RECOMBINATION; DNA REPAIR; DRUG EFFICACY; GENETIC DISORDER; GENETICS; HUMAN; MACROMOLECULE; MAMMAL CELL; METABOLISM; NERVE FIBER DEGENERATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN PROCESSING; PROTEIN STABILITY; REVIEW; SPINOCEREBELLAR DEGENERATION; YEAST CELL;

ANIMALIA; MAMMALIA;

EID: 1242339593     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(04)00056-5     Document Type: Review

References (53)

1. Alani E., Subbiah S., Kleckner N. Analysis of wild-type and rad50 mutants of yeast suggests an intimate relationship between meiotic chromosome synapsis and recombination. Cell. 61:1990;419-436.
2. Caldecott K.W. DNA single-strand break repair and spinocerebellar ataxia. Cell. 112:2003;7-10. a.
3. Caldecott K.W. XRCC1 and DNA strand break repair. DNA Repair (Amst.). 2:2003;955-969. b.
4. Caldecott K., Banks G., Jeggo P. DNA double-strand repair pathways and cellular tolerance to inhibitors of topoisomerase II. Cancer Res. 50:1990;5778-5783.
5. Chen A.Y., Liu L.F. DNA topoisomerases. essential enzymes and lethal targets Annu. Rev. Pharmacol. Toxicol. 34:1994;191-218.
6. Connelly J.C., de Leau E.S., Leach D.R.F. Nucleolytic processing of a protein-bound DNA end by the E. coli SbcD (MR) complex. DNA Repair (Amst.). 2:2003;795-807.
7. Cromie G.A., Connelly J.C., Leach D.R.F. Recombination at double-strand breaks and ends. conserved mechanisms from phage to humans Mol. Cell. 8:2001;1163-1174.
8. D'Amours D., Jackson S.P. The yeast Xrs2 complex functions in S phase checkpoint regulations. Genes Dev. 15:2001;2238-2249.
9. D'Amours D., Jackson S.P. The Mre11 complex. at the crossroads of DNA repair and checkpoint signaling Nat. Rev. Mol. Cell Biol. 3:2002;317-327.
10. Davies D.R., Interthal H., Champoux J.J., Hol W.G.J. The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1. Structure. 10:2002;237-248. a.
11. Davies D.R., Interthal H., Champoux J.J., Hol W.G.J. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures. J. Mol. Biol. 324:2002;917-932. b.
12. Davies D.R., Interthal H., Champoux J.J., Hol W.G.J. Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide. Chem. Biol. 10:2003;139-147.
13. Debéthune L., Kohlhagen G., Grandas A., Pommier Y. Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase. Nucleic Acids Res. 30:2002;1198-1204.
14. Desai S.D., Zhang H., Rodriguez-Baumann A., Yang J.M., Wu X., Gounder M.K., Rubin E.H., Liu L.H. Transcription-dependent degradation of topoisomerase I-DNA covalent complexes. Mol. Cell. Biol. 23:2003;2341-2350.
15. Eisen J.A., Hanawalt P.C. A phylogenomic study of DNA repair genes, proteins and processes. Mutat. Res. 2:1999;795-807.
16. Eng W.K., Faucette L., Johnson R.K., Sternglanz R. Evidence that DNA topoisomerase I is necessary for the effects of camptothecin. Mol. Pharmacol. 34:1989;755-760.
17. Fromme J.C., Verdine G.L. Structure of a trapped endonuclease III-DNA covalent intermediate. EMBO J. 22:2003;3461-3471.
18. Hilbert T.P., Boorstein R.J., Kung H.C., Bolton P.H., Xing D., Cunningham R.P., Teebor G.W. Purification of a mammalian homologue of Escherichia coli Endonuclease III. identification of a bovine pyrimidine hydrate-thymine glycol DNA-glycosylase/AP lyase by irreversible cross linking to a thymine glycol-containing oligodeoxynucleotide Biochemistry. 35:1996;2505-2511.
19. Hong G., Kreuzer K.N. Endonuclease cleavage of blocked replication forks. an indirect pathway of DNA damage from antitumor drug-topoisomerase complexes Proc. Natl. Acad. Sci. USA. 100:2003;5046-5051.
20. Horie K., Tomida A., Sugimoto Y., Yasugi T., Yoshikawa H., Taketani Y., Tsuruo T. SUMO-1 conjugation to intact DNA topoisomerase I amplifies cleavable complex formation induced by camptothecin. Oncogene. 21:2002;7913-7922.
21. Interthal H., Pouliot J.J., Champoux J.J. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc. Natl. Acad. Sci. USA. 98:2001;12009-12014.
22. Jeggo P.A., Caldecott K., Pidsley S., Banks G.R. Sensitivity of chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors. Cancer Res. 49:1989;7057-7063.
23. Keeney S., Giroux C.N., Kleckner N. Meiosis-specific DNA double-strand breaks are catalyzed by Spo11, a member of a widely conserved protein family. Cell. 88:1997;375-384.
24. King M.Y., Redman K.L. RNA methyltransferases utilize two cysteine residues in the formation of 5-methylcytosine. Biochemistry. 41:2002;11218-11225.
25. Kreuzer K.N. Bacteriophage T4, a model system for understanding the mechanism of type II topoisomerase inhibitors. Biochim. Biophys. Acta Gene Struct. Express. 1400:1998;339-347.
26. Lichten M. Meiotic recombination. breaking the genome to save it Curr. Biol. 11:2001;R253-R256.
27. 5C DNA methyl transferases use cysteine residues as catalysts. Proc. Natl. Acad. Sci. USA. 97:2000;8263-8265.
28. Liu C., Pouliot J.J., Nash H.A. Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1. Proc. Natl. Acad. Sci. USA. 99:2002;14970-14975.
29. Nash H.M., Lu R., Lane W.S., Verdine G.L. The critical active-site amine of the human 8-oxoguanine DNA glycosylase, hOgg1. direct identification, ablation and chemical reconstitution Chem. Biol. 4:1997;693-702.
30. Neece S.H., Carles-Kinch K., Tomso D.J., Kreuzer K.N. Role of recombinational repair in sensitivity to an antitumour agent that inhibits bacteriophage T4 type II DNA topoisomerase. Mol. Microbiol. 20:1996;1145-1154.
31. Nitiss J., Wang J.C. DNA topoisomerase-targeting antitumour drugs can be studied in yeast. Proc. Natl. Acad. Sci. USA. 85:1988;7501-7505.
32. Park S.Y., Lam W., Cheng Y.C. X-ray cross-complementing gene I protein plays an important role in camptothecin resistance. Cancer Res. 62:2002;459-465.
33. Plo I., Liao Z.-Y., Barcelo J.M., Kohlhagen G., Caldecott K.W., Weinfeld M., Pommier Y. Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesions. DNA Repair (Amst.). 2:2003;1087-1100.
34. Pommier Y., Kerrigan D., Covey J.M., Kao-Shan C.S., Whang-Peng J. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumour topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) chinese hamster cells. Cancer Res. 48:1988;512-516.
35. Pouliot J.J., Yao K.C., Roberston C.A., Nash H.A. Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes. Science. 286:1999;552-555.
36. Pouliot J.J., Yao K.C., Roberston C.A., Nash H.A. Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae. Genes Cells. 6:2001;677-687.
37. Redinbo M.R., Stewart L., Kuhn P., Champoux J.J., Hol W.G.J. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science. 279:1998;1504-1513.
38. Sabournin M., Nitiss J.L., Nitiss K.C., Tatebayashi K., Ikeda H., Osheroff N. Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks. Nucleic Acids Res. 31:2003;4373-4384.
39. Sharples G.J., Leach D.R. Structural and functional similarities between the SbcCD proteins of Escherichia coli and the RAD50 and MRE11 (RAD32) recombination and repair proteins of yeast. Mol. Microbiol. 17:1995;1215-1217.
40. Simon J.A., Szankasi P., Nguyen D.K., Ludlow C., Dunstan H.M., Roberts C.J., Jensen E.L., Hartwell L.H., Friend S.H. Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae. Cancer Res. 60:2000;328-333.
41. Stohr B.A., Kreuzer K.N. Repair of topoisomerase mediated DNA damage in bacteriophage T4. Genetics. 158:2001;19-28.
42. Stracker T.H., Carson M.D., Weitzman M.D. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature. 418:2002;348-352.
43. Takashima H., Boerkoel C.E., John J., Mustafa Saifi G., Salih M.A.M., Armstrong D., Quiocho F.A., Roa B.B., Nakagawa M., Stockton D.W.et al. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat. Genet. 32:2002;267-272.
44. Usui T., Ogawa H., Petrini J.H.J. A DNA damage response pathway controlled by Tel1 and the Mre11 complex. Mol. Cell. 7:2001;1255-1266.
45. Vance J.R., Wilson T.E. Repair of DNA strand breaks by the overlapping function of lesion-specific and non-lesion-specific DNA 3′ phosphatases. Mol. Cell. Biol. 21:2001;7191-7198.
46. Vance J.R., Wilson T.E. Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing TopI replicative damage. Proc. Natl. Acad. Sci. USA. 99:2002;13669-13674.
47. Wang J.C. DNA topoisomerases. Annu. Rev. Biochem. 65:1996;635-692.
48. Watson J.D. Origin of concatameric T7 DNA. Nature. 239:1972;197-201.
49. Williams S.D., David S.S. Evidence that MutY is a monofunctional glycosylase capable of forming a covalent Schiff base intermediate with substrate DNA. Nucleic Acids Res. 26:1998;5123-5133.
50. Woodworth D.L., Kreuzer K.N. Bacteriophage T4 mutants hypersensitive in an antitumour agent that induces topoisomerase-DNA cleavage complexes. Genetics. 143:1996;1084-1090.
51. Xiao H., Mao Y., Desai S.D., Zhou N., Ting C.Y., Hwang J., Liu L.F. The topoisomerase IIB circular clamp arrests transcription and signals a 26S proteasome pathway. Proc. Natl. Acad. Sci. USA. 100:2003;3239-3244.
52. Yang S.-W., Burgin A.B., Huizenga B.N., Roberston C.A., Yao K.C., Nash H.A. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc. Natl. Acad. Sci. USA. 96:1996;11534-11539.
53. Zharkov D.O., Golan G., Gilboa R., Fernandes A.S., Gerchman S.E., Kycia J.H., Rieger R.A., Grollman A.P., Shoham G. Structural analysis of an Escherichia coli endonuclease VIII covalent reaction intermediate. EMBO J. 21:2002;789-800.